Triglide (fenofibrate)

About Casper Pharmaceuticals

Casper Pharma is a privately held, commercial-stage specialty pharmaceutical company headquartered in Princeton, New Jersey, USA. Founded in 2018, it operates a business model centered on acquiring, developing, and commercializing established and niche pharmaceutical products across several chronic disease areas. The company appears to be revenue-generating with a marketed product, Triglide, and is led by a team of experienced pharmaceutical executives. Its strategy focuses on leveraging a global network to identify and fulfill unmet medical needs with cost-effective therapies.

Therapeutic Areas